Medications
Semaglutide dosage for weight loss, including for non-diabetics
August 4, 2026 · 2 min read
The short answer
For weight loss, semaglutide is prescribed as Wegovy and titrated in steps: 0.25 mg weekly to start, then increases roughly every four weeks through 0.5, 1.0, and 1.7 mg, up to the 2.4 mg weekly maintenance dose, over about 16 to 20 weeks.
The starting dose is intentionally too low to do much; it exists to let your body adjust and reduce nausea. This applies to people without diabetes as well. Your clinician sets and adjusts your dose, and this is general information, not medical advice.
The standard weight-loss schedule
When semaglutide is used specifically for weight loss, it is the brand Wegovy, and it follows a step-up schedule designed to reach a 2.4 mg weekly maintenance dose. A typical plan increases the dose about every four weeks: 0.25 mg weekly for the first four weeks, then 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg, reaching maintenance over roughly 16 to 20 weeks. This applies whether or not you have diabetes; the weight-loss approval and schedule are the same for non-diabetic adults who meet the criteria. Your clinician sets your actual schedule, and this article is general information, not medical advice.
Why it climbs so slowly
The early doses are deliberately too low to produce much weight loss. Their job is to let your digestive system adjust so that nausea, the most common early side effect, stays manageable. Going up too fast is the main cause of rough side effects. If a step is hard on you, clinicians often hold you at the current dose longer rather than pushing ahead. Our post on the GLP-1 titration schedule explains the reasoning, and Wegovy dosing schedule covers the brand specifics.
Ozempic versus Wegovy for weight loss
People sometimes lose weight on Ozempic, which is also semaglutide but approved for type 2 diabetes and dosed up to 2.0 mg. When a clinician prescribes Ozempic for weight, that is off-label use, and the maximum dose differs from Wegovy's 2.4 mg. If your goal is weight loss, the on-label product is Wegovy. See Ozempic for weight loss and Ozempic dosing schedule for that side of it.
The maintenance dose and adjustments
The 2.4 mg weekly dose is the target maintenance dose for weight loss, but not everyone reaches or needs the very top. Some people do well and tolerate best at 1.7 mg, and clinicians individualize this. If side effects at a step are too much, the dose can be held or lowered. Because the schedule spans months and doses change, keeping a clear record of which dose you are on and when it changed, in something like DoseLog, helps you and your clinician stay aligned. Never change your own dose without checking first. This article is general information, not medical advice.
Questions people ask
What is the semaglutide dosage for weight loss?
For weight loss, semaglutide is prescribed as Wegovy and titrated from 0.25 mg weekly up to a 2.4 mg weekly maintenance dose. The dose typically increases about every four weeks through 0.5, 1.0, and 1.7 mg, reaching maintenance over roughly 16 to 20 weeks.
What is the semaglutide dose for weight loss in non-diabetics?
It is the same schedule. The weight-loss approval (Wegovy) is for adults who meet the criteria whether or not they have diabetes, titrating from 0.25 mg up to 2.4 mg weekly. Your clinician confirms eligibility and sets the dose.
Why does semaglutide start at such a low dose?
The 0.25 mg starting dose is intentionally too low to drive much weight loss. It exists to let your digestive system adjust and to reduce nausea. Increasing too quickly is the main cause of severe side effects, which is why the climb is gradual.
Is 2.4 mg the maximum semaglutide dose for weight loss?
Yes, 2.4 mg weekly is the target maintenance dose for weight loss with Wegovy. Not everyone needs the very top dose; some do well at 1.7 mg. Clinicians individualize the dose and can hold or lower it if side effects are difficult.
References
- 1.Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. STEP 1. NEJM 2021. Read on NEJM ↗
- 2.Ozempic and Wegovy (semaglutide) prescribing information: dosing, adverse reactions, and warnings. View label on DailyMed ↗
- 3.Reviews of GLP-1 dose-escalation and tolerability during titration. Find on PubMed ↗
This article is general education, not medical advice. DoseLog is a tracking and reflection tool. Decisions about your medication, dose, and symptoms belong with a licensed clinician.
Keep reading